Menu

Michal Berkner

Partner

mberkner@cooley.com

full contact info

Michal leads cross-border mergers and acquisitions, advising tech and life sciences companies in game-changing M&A, including deSPACs, reverse mergers, negotiated and unsolicited transactions, and joint ventures. Her clients include strategic and private equity buyers and sellers in public and private transactions. She is dual qualified in New York and England and Wales.

Download full bio 

Experience

  • Biote Agrees to Combine With SPAC Haymaker Acquisition Corp. III 

  • Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II 

  • Baylis Medical Agrees to Sell to Boston Scientific for $1.75 Billion 

  • ZOLL Medical Agrees to Acquire Itamar Medical for $538 Million 

  • Brandwatch Agrees to Sell to Cision for $450 Million 

  • View all

Practices & Industries
Education

  • University of Pennsylvania Law School
    JD, 1997

  • Johns Hopkins University
    BA, 1994

Admissions & Credentials

England & Wales

New York

Media & Insight
Rankings & Accolades

    The Legal 500 UK: M&A  (2022)
    Chambers & Partners (UK): Leading Individual - Corporate/ M&A (2022)

Recent Blog Postings

Renegotiating Deal Terms? Delaware Reminds Fiduciaries of Unremitting Duties

Social Distancing From a (Supposed) Life Partner: Early Lessons From Deals Terminated and On the Rocks in the COVID-19 Era

Long-Term Focus: Preparing for Activism + Takeovers Amid COVID-19 Risks

Cooley’s 2019 Tech M&A Year in Review

Cooley's 2019 Life Sciences M&A Year in Review

Taking a Play out of the Financial Acquirer’s Playbook

Use of Earn-Outs to “Bridge” the Valuation Gap

 

 

Contact

mberkner@cooley.com

+44 (0) 20 7556 4321

Locations